Biologics Fill/Finish Services Market by Type of Primary Packaging Container, Type of Biologic, Scale of Operation, Key Therapeutic Areas, Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

Report
539 Pages
May 2021
Region: Global
Roots Analysis
ID: 5397777

Overview

In order to meet the anticipated future demand for biologics fill/finish services in the American and European markets, contract service providers based in these regions have made significant investments in accruing additional capacity for drug product manufacturing and fill/finish

- Chief Commercial Officer, large-sized company

Over the last few decades, as a consequence of the therapeutic efficacy and favorable safety profiles of various marketed candidates and those under development, the biopharmaceutical industry has witnessed tremendous growth. The overwhelming success of this upcoming class of products has prompted both established and novice pharmaceutical innovators to develop assets in this arena. Currently, there are close to 400 approved products and more than 4,000 biologic candidates in clinical trials, being developed for the treatment of a wide variety of diseases. As the number of commercialized products and clinical stage therapy candidates increases, the demand for adequate manufacturing capacities and affiliated capabilities is also on the rise. In the production cycle, the (aseptic) fill/finish process is a crucial step. Biopharmaceutical fill/finish operations are relatively more complicated, involving sterilization of all affiliated components before use, filling in a sterile environment, and the use of appropriate post filling sterilization methods. Even minute errors during the aforementioned step can have catastrophic consequences, resulting in heavy losses for the innovator company. Therefore, it is important for companies to establish fill/finish related expertise and build/maintain the necessary infrastructure.

To meet some the abovementioned challenges, drug developers have not hesitated to outsource fill/finish operations to capable contract service providers. Currently, around 170 companies claim to be actively providing fill/finish services for biologics. As is generally the trend among service providers, stakeholders in this domain are making active attempts to adopt the latest technological innovations, in order to meet the growing demand for fill/finish services, reduce cost of operation/increase efficiency, and comply to evolving safety and regulatory requirements, and thereby, differentiate themselves amidst the competition. Over the last few years, the fill/finish services industry has witnessed more than 120 instances of expansion, most of which were intended to increase capacity. We believe that the companies involved this segment of the industry are likely to continue to undertake similar initiatives to cater to the growing needs of their clientele. In addition, significant partnership activity between sponsors and services providers has also been reported in the recent past; a substantial number of deals were observed to have been inked between vaccine developers and CMOs, focused on the fulfilment of fill/finish requirements for multiple vaccines against COVID-19. Considering the anticipated growth in the biologics market, the corresponding opportunity for fill/finish service providers is expected to grow at a steady pace over the coming years.

Scope of the Report

The “Biologics Fill/Finish Services Market (2nd Edition) by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic (Antibodies, Cell Therapy, Gene Therapy, Oligonucleotides, Recombinant Proteins, Vaccines and Others), Scale of Operation (Preclinical/Clinical and Commercial), Key Therapeutic Areas, Geographical Regions (North America, Europe, Asia Pacific, MENA and Latin America and Rest of the World): Industry Trends and Global Forecasts, 2021-2030” report features an extensive study on the biologics fill/finish service providers. The study features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain.

Amongst other elements, the report includes:

A detailed review of the overall landscape of the companies offering fill/finish services for biopharmaceuticals/biologics, along with analyses based on a number of relevant parameters, such as year of establishment, company size, location of headquarters, location of fill/finish facilities, types of packaging form (ampoules, cartridges, syringes and vials), type of biologic filled (ADC, antibodies, biosimilars, cell therapies, gene therapies, oligonucleotides, peptides/proteins, vaccines, viral products, and others), scale of operation (preclinical, clinical and commercial), type of additional services offered (lyophilization, labelling, quality testing, storage and distribution services) and including details on fill/finish capacity and fill volume range.
A detailed competitiveness analysis of the fill/finish service providers based in different geographies offering services across various packaging types, based on supplier strength (in terms of experience and company size), service strength (in terms of number of fill/finish facilities, geographical reach and scale of operation) and types of biologics handled.
Elaborate profiles of key players based in North America, Europe and Asia-Pacific. Each profile provides an overview of the company, information on its service offerings, fill/finish facilities, financial information (if available), details on partnerships, expansions and recent awards and accolades, and an informed future outlook.
An analysis of the partnerships and collaborations focused on the fill/finish operations of biologic drug products, which were established since 2013, based on year of agreement, type of agreement, scale of operation, types of services mentioned in the deal, types of biologics involved and location of fill/finish facilities involved.
A review of the recent expansions (since 2015) undertaken by biologics fill/finish service providers, including a detailed analysis based on various parameters, such as year of expansion, type of expansion (capacity expansion and new facility), type of packaging form, types of services offered, types of biologics involved, scale of operation (preclinical, clinical and commercial), the most active players and geographical location of the added facility.
An estimate of the global fill/finish capacity for filling of biologics, by taking into consideration the capacities of various fill/finish service providers. The fill/finish capacity has been analyzed in terms of number of units and volume of biologics filled, across various type of packaging containers (ampoules, cartridges, syringes, and vials), for the service providers distributed on the basis of company size (small, mid-sized and large) and geographical location (North America, Europe and Asia Pacific).
An informed estimate of the annual demand for fill/finish of the top 25 biologics, based on various relevant parameters, such as target patient population, dosing frequency, dose strength, type of packaging container and volume of the packaging container of these products.
A regional capability assessment framework, which compares the fill/finish capabiility across key geographies, based on a number of parameters, such as the number of biologic fill/finish service providers, number of biologic fill/finish facilities, number of biologic fill/finish partnerships inked in that particular geographical region, number of facility expansions and installed biologic fill/finish capacity in that particular geographical region.
An analysis to identify the key performance indicators for service providers engaged in this domain, based on information gathered via secondary research and primary research.
A case study to highlight the benefits of using robotic/automated equipment for aseptic fill/finish processes, providing a list of equipment manufacturers providing robots suitable for pharmaceutical operations.
A case study to highlight the role of ready-to-use packaging containers in aseptic fill/finish operations, providing a list of suppliers providing the ready-to-use components.
A discussion on the potential growth areas, such as growing biopharmaceutical pipeline, increasing outsourcing of fill/finish operations, rising focus on self-administration enabling drug delivery devices and growing opportunities in the Asia-Pacific region.

One of the key objectives of this report was to estimate the current market size and the future opportunity in the biologics fill/finish services market, over the coming decade. Based on parameters, such as growth of the overall biopharmaceutical market, cost of goods sold, direct manufacturing costs, share of drug product manufacturing costs and outsourcing trends related to fill/finish operations, we have provided an informed estimate of the likely evolution of the market in the short to mid-term and long term, for the period 2021-2030. In order to provide a detailed future outlook, year-wise projections of the current and future opportunity have been further segmented on the basis of [A] types of packaging containers used for fill/finish (ampoules, cartridges, syringes and vials), [B] scale of operation (preclinical, clinical and commercial), [C] types of biologics (antibodies, cell therapy, gene therapy, oligonucleotides, recombinant proteins, vaccines and others), [D] key therapeutic areas (autoimmune disorders, cardiovascular disorders, infectious disorders, oncological disorders and other disorders), and [E] key geographical regions (North America (US, Canada), Europe (UK, France, Germany, Italy, Spain and rest of the Europe), Asia-Pacific (Japan, China, South Korea, India and Australia), MENA, Latin America and Rest of the World). To account for the uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.

The opinions and insights presented in this report are backed by a deep understanding of key insights generated from both secondary and primary research. The perceptions presented in this study were also influenced by discussions held with senior stakeholders in the industry.

The report features detailed transcripts of interviews held with the following industry and non-industry players:

Gregor Kawaletz (Chief Commercial Officer, IDT Biologika)
Matt Delaney (Vice President Business Development & Marketing, ‎Cytovance Biologics)
Purushottam Singnurkar (Research Director and Head of Formulation Development, Syngene International)
Ales Sima (Business Development Manager, Oncomed Manufacturing)
Amit Chandra (Technology Watch Manager, Yposkesi)
Jos Vergeest (International Business Developer, HALIX)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Questions Answered

Who are the leading contract service providers with expertise in fill/finish services for biologics?
In which regions are majority of the biologic fill/finish facilities located?
What percentage of ampoules, cartridges, vials and syringes are filled annually with biologics?
Which partnership models are most commonly adopted by stakeholders in this industry?
What type of expansion initiatives are being carried out by players in this domain?
What is the current, global demand for biologic fill/finish services?
How is the current and future market opportunity likely to be distributed across key market segments

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Biologics
3.3. Need for Outsourcing Biologics-related Operations
3.4. Introduction to Contract Manufacturing
3.5. Commonly Outsourced Operations in the Biopharmaceutical Industry
3.5.1. Biologics Fill / Finish Operations
3.6. Basic Guidelines for Selecting a Fill / Finish Service Provider
3.7. Advantages of Outsourcing Fill / Finish Operations
3.8. Risks and Challenges of Outsourcing Fill / Finish Operations

4. BIOLOGICS FILL / FINISH SERVICE PROVIDERS: COMPETITIVE LANDSCAPE
4.1. Chapter Overview
4.2. Biologics Fill / Finish Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Fill / Finish Facilities
4.2.5. Analysis by Type of Packaging
4.2.6. Analysis by Type of Biologics Filled
4.2.7. Analysis by Scale of Operation
4.2.8. Analysis by Additional Services Offered
4.2.9. Information on Fill / Finish Capacity

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology and Key Parameters
5.3. Biologics Fill / Finish Service Providers in North America
5.4.1. Players Offering Services in Ampoules
5.4.2. Players Offering Services in Cartridges
5.4.3. Players Offering Services in Syringes
5.4.4. Players Offering Services in Vials
5.5. Biologics Fill / Finish Service Providers in Europe
5.5.1. Players Offering Services in Ampoules
5.5.2. Players Offering Services in Cartridges
5.5.3. Players Offering Services in Syringes
5.5.4. Players Offering Services in Vials
5.6. Biologics Fill / Finish Service Providers in Asia-Pacific and RoW
5.6.1. Players Offering Services in Ampoules
5.6.2. Players Offering Services in Cartridges
5.6.3. Players Offering Services in Syringes
5.6.4. Players Offering Services in Vials

6. BIOLOGICS FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. AbbVie Contract Manufacturing
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Financial Information
6.2.4. Recent Developments and Future Outlook
6.3. BioPharma Solutions
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. BioReliance
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Financial Information
6.4.4. Recent Developments and Future Outlook
6.5. Catalent Biologics
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Financial Information
6.5.4. Recent Developments and Future Outlook
6.6. Patheon
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Financial Information
6.6.4. Recent Developments and Future Outlook

7. BIOLOGICS FILL / FINISH SERVICE PROVIDERS IN EUROPE
7.1. Chapter Overview
7.2. Boehringer Ingelheim BioXcellence
7.2.1. Company Overview
7.2.2. Service Portfolio
7.2.3. Financial Information
7.2.4. Recent Developments and Future Outlook
7.3. Lonza
7.3.1. Company Overview
7.3.2. Service Portfolio
7.3.3. Financial Information
7.3.4. Recent Developments and Future Outlook
7.4. Pierre Fabre
7.4.1. Company Overview
7.4.2. Service Portfolio
7.4.3. Financial Information
7.4.4. Recent Developments and Future Outlook
7.5. Recipharm
7.5.1. Company Overview
7.5.2. Service Portfolio
7.5.3. Financial Information
7.5.4. Recent Developments and Future Outlook
7.6. Wacker Biotech
7.6.1. Company Overview
7.6.2. Service Portfolio
7.6.3. Financial Information
7.6.4. Recent Developments and Future Outlook

8. BIOLOGICS FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC
8.1. Chapter Overview
8.2. Asymchem
8.2.1. Company Overview
8.2.2. Service Portfolio
8.2.3. Financial Information
8.2.4. Recent Developments and Future Outlook
8.3. Samsung Biologics
8.3.1. Company Overview
8.3.2. Service Portfolio
8.3.3. Financial Information
8.3.4. Recent Developments and Future Outlook
8.4. Syngene
8.4.1. Company Overview
8.4.2. Service Portfolio
8.4.3. Financial Information
8.4.4. Recent Developments and Future Outlook
8.5. Takara Bio
8.5.1. Company Overview
8.5.2. Service Portfolio
8.5.3. Financial Information
8.5.4. Recent Developments and Future Outlook
8.6. WuXi Biologics
8.6.1. Company Overview
8.6.2. Service Portfolio
8.6.3. Financial Information
8.6.4. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Biologics Fill / Finish Service Providers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Scale of Operation
9.3.4. Analysis by Type of Service
9.3.5. Analysis by Type of Process
9.3.6. Analysis by Type of Biologic Involved
9.3.7. Most Active Players: Analysis by Number of Partnerships
9.3.8. Geographical Analysis
9.3.8.1. Intercontinental and Intracontinental Agreements
9.3.8.2. Analysis by Geographical Location of Facilities

10. RECENT EXPANSIONS
10.1. Chapter Overview
10.2. Biologics Fill / Finish Service Providers: Recent Expansions
10.2.1. Analysis by Year of Expansion
10.2.2. Analysis by Type of Expansion
10.2.3. Analysis by Type of Packaging Form
10.2.4. Analysis by Type of Service Offered
10.2.5. Analysis by Type of Biologic Involved
10.2.6. Analysis by Type of Biologic Involved and Scale of Operation
10.2.7. Most Active Players: Analysis by Type of Service
10.2.8. Geographical Analysis
10.2.9. Expansions in North America: Analysis by Type of Service Offered and Type of Biologic Involved
10.2.10. Expansions in Europe: Analysis by Type of Service and Type of Biologic
10.2.11. Expansions in Asia-Pacific: Analysis by Type of Service and Type of Biologic

11. CAPACITY ANALYSIS
11.1. Chapter Overview
11.2. Assumptions and Methodology
11.3. Global Fill / Finish Capacity (by Number of Units Filled)
11.3.1. Analysis by Type of Packaging
11.3.2. Analysis by Company Size
11.3.3. Analysis by Scale of Operation
11.3.4. Analysis by Location of Headquarters
11.3.5. Analysis by Location of Fill / Finish Facilities
11.4. Global Fill / Finish Capacity (by Fill Volume)
11.4.1. Analysis by Type of Packaging
11.4.2. Analysis by Company Size
11.4.3. Analysis by Scale of Operation
11.4.4. Analysis by Location of Headquarters
11.4.5. Analysis by Location of Fill / Finish Facilities
11.5. Global Fill / Finish Capacity for Ampoules (by Number of Units Filled)
11.5.1 Analysis by Company Size
11.5.2 Analysis by Scale of Operation
11.5.3. Analysis by Location of Headquarters
11.5.4 Analysis by Location of Fill / Finish Facilities
11.6. Global Fill / Finish Capacity for Ampoules (by Fill Volume)
11.6.1. Analysis by Company Size
11.6.2. Analysis by Scale of Operation
11.6.3. Analysis by Location of Headquarters
11.6.4. Analysis by Location of Fill / Finish Facilities
11.7. Global Fill / Finish Capacity for Cartridges (by Number of Units Filled)
11.7.1. Analysis by Company Size
11.7.2. Analysis by Scale of Operation
11.7.3. Analysis by Location of Headquarters
11.7.4. Analysis by Location of Fill / Finish Facilities
11.8. Global Fill / Finish Capacity for Cartridges (by Fill Volume)
11.8.1. Analysis by Company Size
11.8.2. Analysis by Scale of Operation
11.8.3. Analysis by Location of Headquarters
11.8.4. Analysis by Location of Fill / Finish Facilities
11.9. Global Fill / Finish Capacity for Syringes (by Number of Units Filled)
11.9.1 Analysis by Company Size
11.9.2 Analysis by Scale of Operation
11.9.3. Analysis by Location of Headquarters
11.9.4 Analysis by Location of Fill / Finish Facilities
11.10. Global Fill / Finish Capacity for Syringes (by Fill Volume)
11.10.1. Analysis by Company Size
11.10.2. Analysis by Scale of Operation
11.10.3. Analysis by Location of Headquarters
11.10.4. Analysis by Location of Fill / Finish Facilities
11.11. Global Fill / Finish Capacity for Vials (by Number of Units Filled)
11.11.1 Analysis by Company Size
11.11.2 Analysis by Scale of Operation
11.11.3. Analysis by Location of Headquarters
11.11.4. Analysis by Location of Fill / Finish Facilities
11.12. Global Fill / Finish Capacity for Vials (by Fill Volume)
11.12.1. Analysis by Company Size
11.12.2. Analysis by Scale of Operation
11.12.3. Analysis by Location of Headquarters
11.12.4. Analysis by Location of Fill / Finish Facilities
11.13. Conclusion

12. DEMAND ANALYSIS
12.1. Chapter Overview
12.2. Assumptions and Methodology
12.3. Global Demand for Biologics Fill / Finish Services
12.3.1. Analysis by Type of Packaging
12.3.2. Analysis by Type of Biologic
12.3.3. Analysis by Therapeutic Area
12.3.4. Analysis by Geographical Location
12.4. Demand and Supply Analysis

13. KEY PERFORMANCE INDICATORS FOR BIOLOGIC MANUFACTURING AND FILL / FINISH
13.1. Chapter Overview
13.2. Biologics Manufacturing and Fill / Finish: Key Performance Indicators
13.2.1. Financial Indicators
13.2.1.1. Big Pharma Perspective
13.2.1.2. Contract Manufacturers’ Perspective
13.2.2. Process and Capability-related Indicators
13.2.2.1. Big Pharma Perspective
13.2.2.2. Contract Manufacturers’ Perspective
13.2.3. Market Reputation-related Indicators
13.2.3.1. Big Pharma Perspective
13.2.3.2. Contract Manufacturers’ Perspective
13.2.4. Other Important Performance Indicators
13.3.5. Conclusion

14. REGIONAL CAPABILITY ASSESSMENT
14.1. Chapter Overview
14.2. Assumptions and Key Parameters
14.3. Biologics Fill / Finish Capabilities in North America
14.4. Biologics Fill / Finish Capabilities in Europe
14.5. Biologics Fill / Finish Capabilities in Asia-Pacific Region
14.6. Concluding Remarks

15. MARKET SIZING AND OPPORTUNITY ANALYSIS
15.1. Chapter Overview
15.2. Forecast Methodology
15.3. Overall Biologics Fill / Finish Services Market, 2021-2030
15.3.1. Biologics Fill / Finish Services Market, 2021-2030: Distribution by Type of Packaging
15.3.2. Biologics Fill / Finish Services Market, 2021-2030: Distribution by Scale of Operation
15.3.3. Biologics Fill / Finish Services Market, 2021-2030: Distribution by Type of Biologic
15.3.4. Biologics Fill / Finish Services Market, 2021-2030: Distribution by Therapeutic Area
15.3.5. Biologics Fill / Finish Services Market, 2021-2030: Distribution by Geographical Region
15.3.5.1 Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Countries
15.3.5.2. Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Type of Packaging
15.3.5.3. Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Scale of Operation
15.3.5.4. Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Type of Biologic
15.3.5.5. Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Therapeutic Area
15.3.5.6. Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Countries
15.3.5.7. Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Type of Packaging
15.3.5.8. Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Scale of Operation
15.3.5.9. Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Type of Biologic
15.3.5.10. Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Therapeutic Area
15.3.5.11. Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Countries
15.3.5.12. Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Type of Packaging
15.3.5.13. Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Scale of Operation
15.3.5.14. Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Type of Biologic
15.3.5.15. Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area
15.4. Biologics Fill / Finish Services Market for Ampoules, 2021-2030
15.4.1. Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Scale of Operation
15.4.2. Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Type of Biologic
15.4.3. Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Therapeutic Area
15.4.4. Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Geographical Region
15.4.4.1. Biologics Fill / Finish Services Market for Ampoules in North America, 2021-2030: Distribution by Scale of Operation
15.4.4.2. Biologics Fill / Finish Services Market for Ampoules in North America, 2021-2030: Distribution by Type of Biologic
15.4.4.3. Biologics Fill / Finish Services Market for Ampoules in North America, 2021-2030: Distribution by Therapeutic Area
15.4.4.4. Biologics Fill / Finish Services Market for Ampoules in Europe, 2021-2030: Distribution by Scale of Operation
15.4.4.5. Biologics Fill / Finish Services Market for Ampoules in Europe, 2021-2030: Distribution by Type of Biologic
15.4.4.6. Biologics Fill / Finish Services Market for Ampoules in Europe, 2021-2030: Distribution by Therapeutic Area
15.4.4.7. Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2021-2030: Distribution by Scale of Operation
15.4.4.8. Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2021-2030: Distribution by Type of Biologic
15.4.4.9. Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area
15.5. Biologics Fill / Finish Services Market for Cartridges, 2021-2030
15.5.1. Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Scale of Operation
15.5.2. Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Type of Biologic
15.5.3. Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Therapeutic Area
15.5.4. Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Geographical Region
15.5.4.1. Biologics Fill / Finish Services Market for Cartridges in North America, 2021-2030: Distribution by Scale of Operation
15.5.4.2. Biologics Fill / Finish Services Market for Cartridges in North America, 2021-2030: Distribution by Type of Biologic
15.5.4.3. Biologics Fill / Finish Services Market for Cartridges in North America, 2021-2030: Distribution by Therapeutic Area
15.5.4.4. Biologics Fill / Finish Services Market for Cartridges in Europe, 2021-2030: Distribution by Scale of Operation
15.5.4.5. Biologics Fill / Finish Services Market for Cartridges in Europe, 2021-2030: Distribution by Type of Biologic
15.5.4.6. Biologics Fill / Finish Services Market for Cartridges in Europe, 2021-2030: Distribution by Therapeutic Area
15.5.4.7. Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2021-2030: Distribution by Scale of Operation
15.5.4.8. Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2021-2030: Distribution by Type of Biologic
15.5.4.9. Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area
15.6. Biologics Fill / Finish Services Market for Syringes, 2021-2030
15.6.1. Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Scale of Operation
15.6.2. Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Type of Biologic
15.6.3. Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Therapeutic Area
15.6.4. Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Geographical Region
15.6.4.1. Biologics Fill / Finish Services Market for Syringes in North America, 2021-2030: Distribution by Scale of Operation
15.6.4.2. Biologics Fill / Finish Services Market for Syringes in North America, 2021-2030: Distribution by Type of Biologic
15.6.4.3. Biologics Fill / Finish Services Market for Syringes in North America, 2021-2030: Distribution by Therapeutic Area
15.6.4.4. Biologics Fill / Finish Services Market for Syringes in Europe, 2021-2030: Distribution by Scale of Operation
15.6.4.5. Biologics Fill / Finish Services Market for Syringes in Europe, 2021-2030: Distribution by Type of Biologic
15.6.4.6. Biologics Fill / Finish Services Market for Syringes in Europe, 2021-2030: Distribution by Therapeutic Area
15.6.4.7. Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2021-2030: Distribution by Scale of Operation
15.6.4.8. Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2021-2030: Distribution by Type of Biologic
15.6.4.9. Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area
15.7. Biologics Fill / Finish Services Market for Vials, 2021-2030
15.7.1. Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Scale of Operation
15.7.2. Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Type of Biologic
15.7.3. Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Therapeutic Area
15.7.4. Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Geographical Region
15.7.4.1. Biologics Fill / Finish Services Market for Vials in North America, 2021-2030: Distribution by Scale of Operation
15.7.4.2. Biologics Fill / Finish Services Market for Vials in North America, 2021-2030: Distribution by Type of Biologic
15.7.4.3. Biologics Fill / Finish Services Market for Vials in North America, 2021-2030: Distribution by Therapeutic Area
15.7.4.4. Biologics Fill / Finish Services Market for Vials in Europe, 2021-2030: Distribution by Scale of Operation
15.7.4.5. Biologics Fill / Finish Services Market for Vials in Europe, 2021-2030: Distribution by Type of Biologic
15.7.4.6. Biologics Fill / Finish Services Market for Vials in Europe, 2021-2030: Distribution by Therapeutic Area
15.7.4.7. Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2021-2030: Distribution by Scale of Operation
15.7.4.8. Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2021-2030: Distribution by Type of Biologic
15.7.4.9. Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area

16. FUTURE GROWTH OPPORTUNITIES
16.1. Chapter Overview
16.2. Growing Biopharmaceutical Pipeline
16.3. Increase in Outsourcing of Fill / Finish Activities
16.4. Rising Focus on Self-Administration of Drugs
16.5. Advances in Aseptic Fill / Finish Technologies
16.6. Growing Opportunities in the Asia-Pacific Region

17. CASE STUDY: ROBOTIC SYSTEMS IN FILL / FINISH OPERATIONS
17.1. Chapter Overview
17.2. Contract Service Providers: List of Fill / Finish Equipment
17.3. Role of Robotic Systems in Fill / Finish Operations
17.3.1. Types of Robots Used in Pharmaceutical Operations
17.3.2. Key Considerations for Selecting a Robotic System
17.3.3. Advantages of Robotic Systems
17.3.4. Disadvantages of Robotic Systems
17.4. Companies Providing Robots for Use in the Pharmaceutical Industry
17.5. Companies Providing Isolator based Aseptic Filling Systems
17.6. Concluding Remarks

18. CASE STUDY: READY-TO-USE PACKAGING COMPONENTS FOR ASEPTIC FILL / FINISH
18.1. Chapter Overview
18.2. Role of Ready-to-Use Packaging Components in Aseptic Fill / Finish Operations
18.2.1. Advantages of Ready-to-Use Packaging Components
18.2.2. Disadvantages of Ready-to-Use Packaging Components
18.3. Companies Providing Ready-to-Use Packaging Components
18.4. Concluding Remarks

19. CONCLUDING REMARKS

20. INTERVIEW TRANSCRIPTS
20.1 Chapter Overview
20.2 IDT Biologika
20.2.1. Company Snapshot
20.2.1. Interview Transcript: Gregor Kawaletz, Chief Commercial Officer
20.3 Cytovance Biologics
20.3.1. Company Snapshot
20.3.2. Interview Transcript: Matt Delaney, Vice President of Business Development and Marketing
20.4. Syngene
20.4.1. Company Snapshot
20.4.2. Interview Transcript: Purushottam Singnurkar, Research Director and Head of Formulation Development
20.5 oncomed manufacturing
20.5.1. Company Snapshot
20.5.2. Interview Transcript: Ales Sima, Business Development Manager
20.6 Yposkesi
20.6.1. Company Snapshot
20.6.2. Interview Transcript: Amit, Technology Watch Manager
20.7 HALIX
20.7.1. Company Snapshot
20.7.2. Interview Transcript: Jos Vergeest, International Business Developer

21. APPENDIX 1: TABULATED DATA

22. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures
Figure 3.1 Various Types of Biologics
Figure 3.2 Types of Third-Party Service Providers
Figure 3.3 Commonly Outsourced Operations
Figure 3.4 Steps Involved in Fill / Finish of Biologics
Figure 3.5 Key Considerations for Selecting a CMO Partner
Figure 3.6 Risks and Challenges of Outsourcing Biologics Fill / Finish Operations
Figure 4.1 Biologics Fill / Finish Service Providers: Distribution by Year of Establishment
Figure 4.2 Biologics Fill / Finish Service Providers: Distribution by Company Size
Figure 4.3 Biologics Fill / Finish Service Providers: Distribution by Location of Headquarters
Figure 4.4 Biologics Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Figure 4.5 Biologics Fill / Finish Service Providers: Distribution by Type of Packaging
Figure 4.6 Biologics Fill / Finish Service Providers: Distribution by Type of Biologic Involved and Type of Packaging Form
Figure 4.7 Biologics Fill / Finish Service Providers: Distribution by Scale of Operation
Figure 4.8 Biologics Fill / Finish Service Providers: Distribution by Additional Services Offered
Figure 5.1 Company Competitiveness Analysis: Biologics Fill / Finish Service Providers in North America
Figure 5.2 Company Competitiveness Analysis: Players Offering Services in Ampoules (North America)
Figure 5.3 Company Competitiveness Analysis: Players Offering Services in Cartridges (North America)
Figure 5.4 Company Competitiveness Analysis: Players Offering Services in Syringes (North America)
Figure 5.5 Company Competitiveness Analysis: Players Offering Services in Vials (North America)
Figure 5.6 Company Competitiveness Analysis: Biologics Fill / Finish Service Providers in Europe
Figure 5.7 Company Competitiveness Analysis: Players Offering Services in Ampoules (Europe)
Figure 5.8 Company Competitiveness Analysis: Players Offering Services in Cartridges (Europe)
Figure 5.9 Company Competitiveness Analysis: Players Offering Services in Syringes (Europe)
Figure 5.10 Company Competitiveness Analysis: Players Offering Services in Vials (Europe)
Figure 5.11 Company Competitiveness Analysis: Biologics Fill / Finish Service Providers in (Asia-Pacific and Rest of the World)
Figure 5.12 Company Competitiveness Analysis: Players Offering Services in Ampoules (Asia-Pacific and Rest of the World)
Figure 5.13 Company Competitiveness Analysis: Players Offering Services in Cartridges (Asia-Pacific and Rest of World)
Figure 5.14 Company Competitiveness Analysis: Players Offering Services in Syringes (Asia-Pacific and Rest of the World)
Figure 5.15 Company Competitiveness Analysis: Players Offering Services in Vials (Asia-Pacific and Rest of the World)
Figure 6.1 AbbVie Contract Manufacturing: Overview of Service Portfolio
Figure 6.2 AbbVie: Annual Revenues, 2015-2020 (USD Billion)
Figure 6.3 BioPharma Solutions: Overview of Service Portfolio
Figure 6.4 BioReliance: Overview of Service Portfolio
Figure 6.5 Merck KGaA: Annual Revenues, 2014 - 9M 2020 (EUR Billion)
Figure 6.6 Merck KGaA: Annual Revenues by Business Segmnent, 9M 2020 (EUR Billion)
Figure 6.7 Catalent Biologics: Overview of Service Portfolio
Figure 6.8 Catalent Biologics: Annual Revenues, 2015-2020 (USD Billion)
Figure 6.9 Patheon: Overview of Service Portfolio
Figure 6.10 Thermo Fisher Scientific: Annual Revenues, 2014-9M 2020 (USD Billion)
Figure 7.1 Boehringer Ingelheim BioXcellence: Overview of Service Portfolio
Figure 7.2 Boehringer Ingelheim BioXcellence: Annual Revenues, 2014 - H1 2020 (EUR Billion)
Figure 7.3 Lonza: Overview of Service Portfolio
Figure 7.4 Lonza: Annual Revenues, 2014 - H1 2020 (CHF Million)
Figure 7.5 Pierre Fabre: Overview of Service Portfolio
Figure 7.6 Pierre Fabre: Annual Revenues, 2015 - 2019 (EUR Billion)
Figure 7.7 Recipharm: Overview of Service Portfolio
Figure 7.8 Recipharm: Annual Revenues, 2012 - 9M 2020 (SEK Billion)
Figure 7.9 Recipharm: Revenues by Business Divisions, 9M 2020 (SEK Billion)
Figure 7.10 Wacker Biotech: Overview of Service Portfolio
Figure 7.11 Wacker Chemie: Annual Revenues, 2015 - 2020 (EUR Billion)
Figure 8.1 Asymchem: Overview of Service Portfolio
Figure 8.2 Asymchem: Annual Revenues, 2015-2019 (USD Million)
Figure 8.3 ChemPartner: Overview of Service Portfolio
Figure 8.4 Samsung Biologics: Overview of Service Portfolio
Figure 8.5 Samsung Biologics: Annual Revenues, FY 2016 - FY 2020 (KRW Billion)
Figure 8.6 Syngene: Overview of Service Portfolio
Figure 8.7 Syngene: Annual Revenues, FY 2016 – Q3 FY 2021 (INR Million)
Figure 8.8 Takara Bio: Overview of Service Portfolio
Figure 8.9 Takara Bio: Annual Revenues, FY 2016 - H1 FY 2021 (JPY Billion)
Figure 8.10 WuXi Biologics: Overview of Service Portfolio
Figure 8.11 WuXi Biologics: Annual Revenues, 2014 - H1 2020 (RMB Million)
Figure 9.1 Partnerships and Collaborations: Cumulative Trend by Year, 2013-2020
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Scale of Operation
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Service
Figure 9.5 Partnerships and Collaborations: Distribution by Types of Process
Figure 9.6 Partnerships and Collaborations: Distribution by Type of Biologic Involved and Type of Service Offered
Figure 9.7 Partnerships and Collaborations: Most Active Players
Figure 9.8 Partnerships and Collaborations: Geographical Analysis
Figure 9.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 9.10 Partnerships and Collaborations: Distribution by Geographical Location of Facilities
Figure 10.1 Recent Expansions: Distribution by Year of Expansion, 2013-2021 (till January)
Figure 10.2 Recent Expansions: Distribution by Type of Expansion
Figure 10.3 Recent Expansions: Distribution by Type of Packaging Form
Figure 10.4 Recent Expansions: Distribution by Type of Expansion and Type of Service
Figure 10.5 Recent Expansions: Distribution by Type of Biologic Involved
Figure 10.6 Recent Expansions: Distribution by Type of Biologic Involved and Scale of Operation
Figure 10.7 Recent Expansions: Distribution by Geographical Location
Figure 10.8 Recent Expansions: Most Active Players
Figure 10.9 Recent Expansions: Distribution by Location of Expansion Project
Figure 10.10 Recent Expansions in North America: Distribution by Type of Service Offered and Type of Biologic Involved
Figure 10.11 Recent Expansions in Europe: Distribution by Type of Service and Type of Biologic
Figure 10.12 Recent Expansions in Asia-Pacific: Distribution by Type of Service and Type of Biologic
Figure 11.1 Capacity for Filling Ampoules: Distribution by Company Size (Sample Data Set)
Figure 11.2 Capacity for Filling Cartridges: Distribution by Company Size (Sample Data Set)
Figure 11.3 Capacity for Filling Syringes: Distribution by Company Size (Sample Data Set)
Figure 11.4 Capacity for Filling Vials: Distribution by Company Size (Sample Data Set)
Figure 11.5 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Type of Packaging (Million Units)
Figure 11.6 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Company Size (Million Units)
Figure 11.7 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Scale of Operation (Million Units)
Figure 11.8 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Location of Headquarters (Million Units)
Figure 11.9 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.10 Global Fill / Finish Capacity (by Fill Volume): Distribution by Type of Packaging (Kilo Liters)
Figure 11.11 Global Fill / Finish Capacity (by Fill Volume): Distribution by Company Size (Kilo Liters)
Figure 11.12 Global Fill / Finish Capacity (by Fill Volume): Distribution by Scale of Operation (Kilo Liters)
Figure 11.13 Global Fill / Finish Capacity (by Fill Volume): Distribution by Location of Headquarters (Kilo Liters)
Figure 11.14 Global Fill / Finish Capacity (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Kilo Liters)
Figure 11.15 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.16 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Range of Capacity by Company Size
Figure 11.17 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.18 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.19 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.20 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.21 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.22 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.23 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.24 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Figure 11.25 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.26 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Range of Capacity by Company Size
Figure 11.27 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.28 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.29 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.30 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.31 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.32 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.33 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.34 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Figure 11.35 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.36 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.37 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.38 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.39 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.40 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.41 Global Fill / Finish Capacity for Syringes (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.42 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.43 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.44 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Figure 11.45 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.46 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Range of Capacity by Company Size
Figure 11.47 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.48 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.49 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.50 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Company Size (Kilo Liters)
Figure 11.51 Global Fill / Finish Capacity for Vials (by Fill Volume): Range of Capacity by Company Size (Kilo Liters)
Figure 11.52 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Scale of Operation (Kilo Liters)
Figure 11.53 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Location of Headquarters (Kilo Liters)
Figure 11.54 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Figure 12.1 Global Demand for Biologics Fill / Finish Services (Million Liters)
Figure 12.2 Global Demand for Biologics Fill / Finish Services: Distribution by Type of Packaging (Kilo Liters)
Figure 12.3 Global Demand for Biologics Fill / Finish Services: Distribution by Type of Biologic Involved (Kilo Liters)
Figure 12.4 Global Demand for Biologics Fill / Finish Services: Distribution by Therapeutic Area (Kilo Liters)
Figure 12.5 Global Demand for Biologics Fill / Finish Services: Distribution by Geographical Location (Kilo Liters)
Figure 12.6 Global Biologics Fill / Finish Services: Demand and Supply, 2021-2030
Figure 13.1 Biologics Manufacturing and Fill / Finish: Key Performance Indicators (KPIs)
Figure 13.2 Financial Indicators: Comparative Analysis of KPIs Considered by Big Pharma Companies
Figure 13.3 Financial Indicators: Big Pharma Perspective
Figure 13.4 Financial Indicators: Contract Manufacturers’ Perspective
Figure 13.5 Process / Capability-related Indicators: Comparative Analysis of KPIs of Big Pharma Companies
Figure 13.6 Process / Capability-related Indicators: Big Pharma Perspective
Figure 13.7 Process / Capability-related Indicators: Contract Manufacturers’ Perspective
Figure 13.8 Market Reputation-related Indicators: Comparative Analysis of KPIs of Big Pharma Companies
Figure 13.9 Market Reputation-related Indicators: Big Pharma Perspective
Figure 13.10 Market Reputation-related Indicators: Contract Manufacturers’ Perspective
Figure 13.11 Other Performance Indicators: Contract Manufacturers’ Perspective
Figure 14.1 Regional Capability Assessment: Biologic Fill / Finish Capabilities in North America
Figure 14.2 Regional Capability Assessment: Biologic Fill / Finish Capabilities in Europe
Figure 14.3 Regional Capability Assessment: Biologic Fill / Finish Capabilities in Asia-Pacific and Rest of the World
Figure 14.4 Regional Capability Assessment: Comparison of Capabilities across Different Regions
Figure 15.1 Overall Biologics Fill / Finish Services Market, 2021-2030 (USD Billion)
Figure 15.2 Biologics Fill / Finish Services Market, 2021-2030: Distribution by Type of Packaging (USD Million)
Figure 15.3 Biologics Fill / Finish Services Market, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.4 Biologics Fill / Finish Services Market, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.5 Biologics Fill / Finish Services Market, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.6 Biologics Fill / Finish Services Market, 2021-2030: Distribution by Geographical Region (USD Million)
Figure 15.7 Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Countries (USD Million)
Figure 15.8 Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Type of Packaging (USD Million)
Figure 15.9 Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.10 Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.11 Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.12 Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Countries (USD Million)
Figure 15.13 Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Type of Packaging (USD Million)
Figure 15.14 Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.15 Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.16 Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.17 Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Countries (USD Million)
Figure 15.18 Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Type of Packaging (USD Million)
Figure 15.19 Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.20 Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.21 Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.22 Biologics Fill / Finish Services Market for Ampoules, 2021-2030 (USD Million)
Figure 15.23 Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.24 Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.25 Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.26 Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Geographical Region (USD Million)
Figure 15.27 Biologics Fill / Finish Services Market for Ampoules in North America, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.28 Biologics Fill / Finish Services Market for Ampoules in North America, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.29 Biologics Fill / Finish Services Market for Ampoules in North America, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.30 Biologics Fill / Finish Services Market for Ampoules in Europe, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.31 Biologics Fill / Finish Services Market for Ampoules in Europe, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.32 Biologics Fill / Finish Services Market for Ampoules in Europe, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.33 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.34 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.35 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.36 Biologics Fill / Finish Services Market for Cartridges, 2021-2030 (USD Million)
Figure 15.37 Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.38 Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.39 Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.40 Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Geographical Region (USD Million)
Figure 15.41 Biologics Fill / Finish Services Market for Cartridges in North America, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.42 Biologics Fill / Finish Services Market for Cartridges in North America, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.43 Biologics Fill / Finish Services Market for Cartridges in North America, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.44 Biologics Fill / Finish Services Market for Cartridges in Europe, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.45 Biologics Fill / Finish Services Market for Cartridges in Europe, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.46 Biologics Fill / Finish Services Market for Cartridges in Europe, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.47 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.48 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.49 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.50 Biologics Fill / Finish Services Market for Syringes, 2021-2030 (USD Million)
Figure 15.51 Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.52 Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.53 Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.54 Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Geographical Region (USD Million)
Figure 15.55 Biologics Fill / Finish Services Market for Syringes in North America, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.56 Biologics Fill / Finish Services Market for Syringes in North America, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.57 Biologics Fill / Finish Services Market for Syringes in North America, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.58 Biologics Fill / Finish Services Market for Syringes in Europe, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.59 Biologics Fill / Finish Services Market for Syringes in Europe, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.60 Biologics Fill / Finish Services Market for Syringes in Europe, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.61 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.62 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.63 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.64 Biologics Fill / Finish Services Market for Vials, 2021-2030 (USD Million)
Figure 15.65 Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.66 Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.67 Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.68 Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Geographical Region (USD Million)
Figure 15.69 Biologics Fill / Finish Services Market for Vials in North America, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.70 Biologics Fill / Finish Services Market for Vials in North America, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.71 Biologics Fill / Finish Services Market for Vials in North America, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.72 Biologics Fill / Finish Services Market for Vials in Europe, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.73 Biologics Fill / Finish Services Market for Vials in Europe, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.74 Biologics Fill / Finish Services Market for Vials in Europe, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.75 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.76 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.77 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 16.1 Growth Opportunities for Biologics Fill / Finish Service Providers
Figure 16.2 New Molecular Entities Approved by the FDA, 2011-2020
Figure 17.1 Key Considerations for Selecting a Robotic System
Figure 17.2 Advantages of Robotic Systems in Pharmaceutical Operations
Figure 18.1 Key Drivers of Ready-to-Use Platform
Figure 19.1 Concluding Remarks: Current Biologic Fill / Finish Service Providers Market Landscape Summary
Figure 19.2 Concluding Remarks: Recent Partnerships
Figure 19.3 Concluding Remarks: Recent Expansions
Figure 19.4 Concluding Remarks: Capacity Analysis
Figure 19.5 Concluding Remarks: Demand Analysis
Figure 19.6 Concluding Remarks: Market Sizing and Opportunity Analysis for Biologic Fill / Finish Services Market

List Of Tables
Table 3.1 Best-Selling Drugs of 2019
Table 4.1 Biologics Fill / Finish Service Providers: List of Companies
Table 4.2 Biologics Fill / Finish Service Providers: Information on Type of Packaging
Table 4.3 Biologics Fill / Finish Service Providers: Information on Type of Biologic Involved
Table 4.4 Biologics Fill / Finish Service Providers: Information on Scale of Operation
Table 4.5 Biologics Fill / Finish Service Providers: Information on Additional Services Offered
Table 4.6 Biologics Fill / Finish Service Providers: Information on Fill / Finish Capacity
Table 6.1 Biologics Fill / Finish Service Providers in North America: List of Profiled Companies
Table 6.2 AbbVie Contract Manufacturing: Company Overview
Table 6.3 AbbVie Contract Manufacturing: Overview of Service Portfolio
Table 6.4 AbbVie Contract Manufacturing: Sterile Manufacturing Facilities
Table 6.5 AbbVie Contract Manufacturing: Recent Developments and Future Outlook
Table 6.6 BioPharma Solutions: Company Overview
Table 6.7 BioPharma Solutions: Overview of Service Portfolio
Table 6.8 BioPharma Solutions: Sterile Manufacturing Facilities
Table 6.9 BioPharma Solutions: Recent Developments and Future Outlook
Table 6.10 BioReliance: Company Overview
Table 6.11 BioReliance: Overview of Service Portfolio
Table 6.12 BioReliance: Sterile Manufacturing Facilities
Table 6.13 BioReliance: Recent Developments and Future Outlook
Table 6.14 Catalent Biologics: Company Overview
Table 6.15 Catalent Biologics: Overview of Service Portfolio
Table 6.16 Catalent Biologics: Sterile Manufacturing Facilities
Table 6.17 Catalent Biologics: Recent Developments and Future Outlook
Table 6.18 Patheon: Company Overview
Table 6.19 Patheon: Overview of Service Portfolio
Table 6.20 Patheon: Sterile Manufacturing Facilities
Table 6.21 Patheon: Recent Developments and Future Outlook
Table 7.1 Biologics Fill / Finish Service Providers in Europe: List of Profiled Companies
Table 7.2 Boehringer Ingelheim BioXcellence: Company Overview
Table 7.3 Boehringer Ingelheim BioXcellence: Overview of Service Portfolio
Table 7.4 Boehringer Ingelheim BioXcellence: Sterile Manufacturing Facilities
Table 7.5 Boehringer Ingelheim BioXcellence: Recent Developments and Future Outlook
Table 7.6 Lonza: Company Overview
Table 7.7 Lonza: Overview of Service Portfolio
Table 7.8 Lonza: Sterile Manufacturing Facilities
Table 7.9 Lonza: Recent Developments and Future Outlook
Table 7.10 Pierre Fabre: Company Overview
Table 7.11 Pierre Fabre: Overview of Service Portfolio
Table 7.12 Pierre Fabre: Sterile Manufacturing Facilities
Table 7.13 Pierre Fabre: Recent Developments and Future Outlook
Table 7.14 Recipharm: Company Overview
Table 7.15 Recipharm: Overview of Service Portfolio
Table 7.16 Recipharm: Sterile Manufacturing Facilities
Table 7.17 Recipharm: Recent Developments and Future Outlook
Table 7.18 Wacker Biotech: Company Overview
Table 7.19 Wacker Biotech: Overview of Service Portfolio
Table 7.20 Wacker Biotech: Sterile Manufacturing Facilities
Table 7.21 Wacker Biotech: Recent Developments and Future Outlook
Table 8.1 Biologics Fill / Finish Service Providers in Asia-Pacific: List of Profiled Companies
Table 8.2 Asymchem: Company Overview
Table 8.3 Asymchem: Overview of Service Portfolio
Table 8.4 Asymchem: Sterile Manufacturing Facilities
Table 8.5 Asymchem: Recent Developments and Future Outlook
Table 8.6 Syngene: Company Overview
Table 8.7 Syngene: Overview of Service Portfolio
Table 8.8 Syngene: Recent Developments and Future Outlook
Table 8.9 Takara Bio: Company Overview
Table 8.10 Takara Bio: Overview of Service Portfolio
Table 8.11 Takara Bio: Recent Developments and Future Outlook
Table 8.12 WuXi Biologics: Company Overview
Table 8.13 WuXi Biologics: Overview of Drug Product Services
Table 8.14 WuXi Biologics: Sterile Manufacturing Facilities
Table 8.15 WuXi Biologics: Recent Developments and Future Outlook
Table 9.1 Biologics Fill / Finish Service Providers: Partnerships and Collaborations, 2013-2020
Table 9.2 Partnerships and Collaborations: Information on Types of Services Offered, 2013-2020
Table 9.3 Partnerships and Collaborations: Information on Types of Biologics Involved, 2013-2020
Table 10.1 Biologics Fill / Finish Service Providers: Recent Expansions, 2013-2021 (till January)
Table 10.2 Recent Expansions, 2013-2021 (till January): Information on Type of Packaging
Table 10.3 Recent Expansions, 2013-2021 (till January): Information on Types of Services
Table 10.4 Recent Expansions, 2013-2021 (till January): Information on Types of Biologics
Table 11.1 Average Fill / Finish Capacity for Ampoules (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.2 Average Fill / Finish Capacity for Cartridges (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.3 Average Fill / Finish Capacity for Syringes (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.4 Average Fill / Finish Capacity for Vials (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.5 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size
Table 11.6 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size
Table 11.7 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size
Table 11.8 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size
Table 11.9 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Company Size
Table 11.10 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size
Table 11.11 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size
Table 11.12 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Company Size
Table 12.1 Global Biologics Fill / Finish Services: Annual Supply for Outsourcing, 2021-2030 (Million Liters)
Table 16.1 Patent Expiry of Biologics, 2021-2023
Table 17.1 Biologics Fill / Finish Service Providers: Information on Fill / Finish Equipment Used
Table 17.2 List of Pharmaceutical Robotics Manufacturers
Table 17.3 Isolator based Aseptic Filling Systems: Information on Compatible Primary Container
Table 18.1 List of Companies Supplying Ready-to-Use Packaging Components
Table 19.1 Biologics Fill / Finish Service Providers: Summary of the Report
Table 21.1 Biologics Fill / Finish Service Providers: Distribution by Year of Establishment
Table 21.2 Biologics Fill / Finish Service Providers: Distribution by Company Size
Table 21.3 Biologics Fill / Finish Service Providers: Distribution by Location of Headquarters
Table 21.4 Biologics Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Table 21.5 Biologics Fill / Finish Service Providers: Distribution by Type of Packaging
Table 21.6 Biologics Fill / Finish Service Providers: Distribution by Type of Biologic Involved and Type of Packaging Form
Table 21.7 Biologics Fill / Finish Service Providers: Distribution by Scale of Operation
Table 21.8 Biologics Fill / Finish Service Providers: Distribution by Type of Additional Services Offered
Table 21.9 AbbVie: Annual Revenues, 2015 - 2020 (USD Billion)
Table 21.10 Merck KGaA: Annual Revenues, 2014 - 9M 2020 (EUR Billion)
Table 21.11 Merck KGaA: Annual Revenues by Business Segment, 9M 2020 (EUR Billion)
Table 21.12 Catalent Biologics: Annual Revenues, 2015 - 2020 (USD Billion)
Table 21.13 Thermo Fisher Scientific: Annual Revenues, 2014 - 9M 2020 (USD Billion)
Table 21.14 Patheon: Annual Revenues, 2012 - H1 2017 (USD Million)
Table 21.15 Boehringer Ingelheim BioXcellence: Overview of Service Portfolio
Table 21.16 Boehringer Ingelheim BioXcellence: Annual Revenues, 2014 - H1 2020 (EUR Billion)
Table 21.17 Lonza: Annual Revenues, 2014 - H1 2020 (CHF Million)
Table 21.18 Pierre Fabre: Annual Revenues, 2015 - 2018 (EUR Billion)
Table 21.19 Recipharm: Annual Revenues, 2012 - 9M 2020 (SEK Billion)
Table 21.20 Recipharm: Revenues by Business Divisions, 9M 2020 (SEK Billion)
Table 21.21 Wacker Chemie: Annual Revenues, 2015 - 2020 (EUR Billion)
Table 21.22 Asymchem: Annual Revenues, 2015 - 2019 (USD Million)
Table 21.23 Samsung Biologics: Annual Revenues, FY 2016 - FY 2020 (KRW Billion)
Table 21.24 Syngene: Annual Revenues, FY 2016 - 9M FY 2021 (INR Million)
Table 21.25 Takara Bio: Annual Revenues, FY 2016 - H1 FY 2021 (JPY Billion)
Table 21.26 WuXi Biologics: Annual Revenues, 2014 - H1 2020 (RMB Million)
Table 21.27 Partnerships and Collaborations: Cumulative Year-wise Trend, 2013-2020
Table 21.28 Partnerships and Collaborations: Distribution by Type of Partnership
Table 21.29 Partnerships and Collaborations: Distribution by Scale of Operation
Table 21.30 Partnerships and Collaborations: Distribution by Types of Services Offered
Table 21.31 Partnerships and Collaborations: Distribution by Types of Processes
Table 21.32 Partnerships and Collaborations: Distribution by Types of Biologics Involved and Type of Services Offered
Table 21.33 Partnerships and Collaborations: Most Active Players
Table 21.34 Partnerships and Collaborations: Geographical Analysis
Table 21.35 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 21.36 Partnerships and Collaborations: Distribution by Geographical Location of Facilities
Table 21.37 Recent Expansions: Distribution by Year of Expansion, 2013-2021 (till January)
Table 21.38 Recent Expansions: Distribution by Type of Expansion
Table 21.39 Recent Expansions: Distribution by Type of Packaging
Table 21.40 Recent Expansions: Distribution by Type of Expansion and Type of Service
Table 21.41 Recent Expansions: Distribution by Type of Biologic Involved
Table 21.42 Recent Expansions: Distribution by Type of Biologic and Scale of Operation
Table 21.43 Recent Expansions: Distribution by Geographical Location
Table 21.44 Recent Expansions: Distribution by Most Active Players
Table 21.45 Recent Expansions: Distribution by Location of Expansion Project
Table 21.46 Recent Expansions in North America: Distribution by Type of Service Offered and Type of Biologic Involved
Table 21.47 Recent Expansions in Europe: Distribution by Type of Service and Type of Biologic
Table 21.48 Recent Expansions in Asia-Pacific: Distribution by Type of Service and Type of Biologic
Table 21.49 Capacity for Filling Ampoules: Distribution by Company Size (Sample Data Set)
Table 21.50 Capacity for Filling Cartridges: Distribution by Company Size (Sample Data Set)
Table 21.51 Capacity for Filling Syringes: Distribution by Company Size (Sample Data Set)
Table 21.52 Capacity for Filling Vials: Distribution by Company Size (Sample Data Set)
Table 21.53 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Type of Packaging (Million Units)
Table 21.54 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Company Size (Million Units)
Table 21.55 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Scale of Operation (Million Units)
Table 21.56 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Location of Headquarters (Million Units)
Table 21.57 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.58 Global Fill / Finish Capacity (by Fill Volume): Distribution by Type of Packaging (Kilo Liters)
Table 21.59 Global Fill / Finish Capacity (by Fill Volume): Distribution by Company Size (Kilo Liters)
Table 21.60 Global Fill / Finish Capacity (by Fill Volume): Distribution by Scale of Operation (Kilo Liters)
Table 21.61 Global Fill / Finish Capacity (by Fill Volume): Distribution by Location of Headquarters (Kilo Liters)
Table 21.62 Global Fill / Finish Capacity (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Kilo Liters)
Table 21.63 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.64 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.65 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.66 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.67 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size (Liters)
Table 21.68 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.69 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.70 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Table 21.71 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.72 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.73 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.74 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.75 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size (Liters)
Table 21.76 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.77 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.78 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Table 21.79 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Company Size
Table 21.80 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.81 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.82 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.83 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size (Liters)
Table 21.84 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.85 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.86 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Table 21.87 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.88 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.89 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.90 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.91 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Company Size (Liters)
Table 21.92 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.93 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.94 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Table 21.95 Global Demand for Biologics Fill / Finish Services (Million Liters)
Table 21.96 Global Demand for Biologics Fill / Finish Services: Distribution by Type of Packaging (Kilo Liters)
Table 21.97 Global Demand for Biologics Fill / Finish Services: Distribution by Type of Biologic (Kilo Liters)
Table 21.98 Global Demand for Biologics Fill / Finish Services: Distribution by Therapeutic Area (Kilo Liters)
Table 21.99 Global Demand for Biologics Fill / Finish Services: Distribution by Geographical Location (Kilo Liters)
Table 21.100 Global Biologics Fill / Finish Services: Demand and Supply, 2021-2030
Table 21.101 Overall Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2021-2030 (USD Billion)
Table 21.102 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Packaging (USD Million)
Table 21.103 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.104 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.105 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.106 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Geographical Region (USD Million)
Table 21.107 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Countries (USD Million)
Table 21.108 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Packaging (USD Million)
Table 21.109 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.110 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.111 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.112 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Countries (USD Million)
Table 21.113 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Packaging (USD Million)
Table 21.114 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.115 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.116 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.117 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Countries (USD Million)
Table 21.118 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Packaging (USD Million)
Table 21.119 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.120 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.121 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.122 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2021-2030 (USD Million)
Table 21.123 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.124 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.125 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.126 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Geographical Region (USD Million)
Table 21.127 Biologics Fill / Finish Services Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.128 Biologics Fill / Finish Services Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.129 Biologics Fill / Finish Services Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.130 Biologics Fill / Finish Services Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.131 Biologics Fill / Finish Services Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.132 Biologics Fill / Finish Services Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.133 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.134 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.135 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.136 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2021-2030 (USD Million)
Table 21.137 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.138 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.139 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.140 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Geographical Region (USD Million)
Table 21.141 Biologics Fill / Finish Services Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.142 Biologics Fill / Finish Services Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.143 Biologics Fill / Finish Services Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.144 Biologics Fill / Finish Services Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.145 Biologics Fill / Finish Services Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.146 Biologics Fill / Finish Services Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.147 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.148 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.149 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.150 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2021-2030 (USD Million)
Table 21.151 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.152 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.153 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.154 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Geographical Region (USD Million)
Table 21.155 Biologics Fill / Finish Services Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.156 Biologics Fill / Finish Services Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.157 Biologics Fill / Finish Services Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.158 Biologics Fill / Finish Services Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.159 Biologics Fill / Finish Services Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.160 Biologics Fill / Finish Services Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.161 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.162 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.163 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.164 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2021-2030 (USD Million)
Table 21.165 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.166 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.167 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.168 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Geographical Region (USD Million)
Table 21.169 Biologics Fill / Finish Services Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.170 Biologics Fill / Finish Services Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.171 Biologics Fill / Finish Services Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.172 Biologics Fill / Finish Services Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.173 Biologics Fill / Finish Services Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.174 Biologics Fill / Finish Services Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.175 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.176 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.177 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.178 New Molecular Entities Approved by the FDA, 2011-2020

Companies Mentioned

3P Biopharmaceuticals
Aalto Scientific
ABB
AbbVie
AbbVie Contract Manufacturing
Abzena
ACG
ACIC Pharmaceutical Machinery
AdaptVac
ADC Biotechnology
Adimmune
Advanced BioScience Laboratories
Affinity Life Sciences
Afton Scientific
Agilis Biotherapeutics
AJ Biologics
Ajinomoto Bio-Pharma Services
Akron Biotech
AKSO
Akums Drugs and Pharmaceuticals
Alanza
Alcami
Alcon
Aldevron
Alkermes
Althea
Althea Technologies
Amatsigroup
Ambica Pharma Machines
Amgen
Amicus Therapeutics
AMRI
Anchiano Therapeutics
Anchor Mark
Anthos Therapeutics
apceth Biopharma
APG Europe
Aptar Pharma
Aptuit
Arabio
ARaymond Life
Arch Biopartners
ARISTO
Aseptic Technologies
Asklepios BioPharmaceutical
AST
AstraZeneca
Asymchem
Ausia BioTech
Austrianova
Automated Systems of Tacoma
Avrio Biopharmaceuticals
AWS Bio-Pharma Technologies
Axcellerate Pharma
Baccinex
Bausch & Ströbel
BAUSCH Advanced Technology Group (BATG)
Bayer
Berkshire Sterile Manufacturing
Binex
Bio Elpida
Bio-Concept Laboratories
BioConnection
Biofabri
Biogen
BioMARC
Biomay
Biomedical Advanced Research and Development Authority (BARDA)
BioNTech IMFS
BioPharma Solutions
BioReliance
BioTechLogic
BioTechnique
BioTechniques
Biovian
BirgiMefar
Boehringer Ingelheim BioXcellence
Bolt Biotherapeutics
Boston Children’s Hospital
Bristol-Myers Squibb
Bryllan
BSP Pharmaceuticals
Burrard Pharmaceuticals
Cangene Corporation
Canton Biologics
CARBOGEN AMCIS
Catalent Biologics
Celgene
Cell Culture Company
Cellin Technologies
Celonic
Cenexi
Cerbios-Pharma
Cerium Pharmaceuticals
ChemPartner
Chime Biologics
China Gateway Biologics
CinnaGen
Citryll
CMAB Biopharma
CMC Biologics
Coalition for the Promotion of Innovations for Epidemic Preparedness (CEPI)
Cobra Biologics
Cognate BioServices
Coldstream Laboratories
Colorado State University
Columbus Venture Partners
Comecer
Cook Pharmica
CordenPharma
Creative Biolabs
Crystal Pharma
CureVac
CytoDyn
Cytovance Biologics
Daikyo Seiko
Dalton Pharma Services
Dara Pharma
Datwyler Sealing Solutions
DENSO
Dhruv Life Sciences
Disposable Lab
DM Bio
DSM Pharmaceutical Products
DWK Life Sciences
EirGen Pharma
EirGenix
Eli Lilly
EMA Pharmaceuticals
Emcure Pharmaceuticals
Emergent BioSolutions
Esco Aster
Etinpro
EuBiologics
EUCODIS Bioscience
Eurofins BioPharma Product Testing Netherlands
Eurofins Scientific
EVER Pharma
Exelead
Experic
Extract Technology
FANUC America
Fareva
FinVector
Formosa Laboratories
Fresenius Kabi Contract Manufacturing
FUJIFILM Diosynth Biotechnologies
GC Pharma
GEA
Genentech
GeneQuantum Healthcare
Generic Specialities
GenIbet Biopharmaceuticals
Genovior Biotech
Genprex
Gerresheimer
Getinge
GigaGen
Gilead
GlaxoSmithKline
GLyPharma
Goodwin Biotechnology
GP Pharm
Grand River Aseptic Manufacturing
Groninger
GTCR
Gulf Biotech
HALIX
Hameln Pharma
Handl Therapeutics
Hansa Biopharma
Hapten Sciences
Health Biotech
Healthcare Pharmaceuticals
Hepalink
Hetero Drugs
Hisun Pharmaceuticals USA
Hookipa Pharma
Hospira One 2 One
Humanigen
Hybio Pharmaceutical
Hycult Biotech
IDT Biologika
IMA Group
Immune Pharmaceuticals
Immunex
Infectious Disease Research Institute
Injectalia
Intas Pharmaceuticals
Integrity Bio
Irvine Pharmaceutical Services
Istituto Biochimico Italiano Giovanni Lorenzini
Janssen Pharmaceuticals
JHL Biotech
Johnson & Johnson
JOINN Biologics
Jubilant HollisterStier
Kanda BioTech
Kaneka Eurogentec
Kawasaki Heavy Industries
Kaysersberg Pharmaceuticals
Kemwell Biopharma
Klenzaids
Kohlberg and Mubadala
KUKA
Laboratorios Farmaceuticos ROVI
Laekna Therapeutics
LamKap Bio
Lava Therapeutics
Liof Pharma
Lonza
LSNE Contract Manufacturing
Lubrizol
LuinaBio
Lyophilization Technology
M&O Perry Industries
MabPlex
Madison Dearborn Partners
Marchesini Group
MassBiologics
Massman Automation Designs
MaSTherCell
MEDInstill
Merck
Microdermics
Millmount Healthcare (acquired by PCI Pharma Services)
Miltenyi Biotec
Minaris Regenerative Medicine
Mitsubishi Electric
Moderna
Mycenax Biotech
Najít Technologies
National Institutes of Health
NBE-Therapeutics
Nikon CeLL innovation
Ningbo Zhengli Pharmaceutical Packing
Nipro PharmaPackaging
Nitto Avecia Pharma Services
Nitto Denko Avecia
Northway Biotechpharma
Nova Laboratories
Novartis
Novasep
Noveome Biotherapeutics
Novex Innovations
Novo Nordisk
Ology Bioservices
OmniChem
Ompi
OMRON Industrial Automation
oncomed manufacturing
Oncotec Pharma Produktion
OPKO Health
OPTIMA
Oryn Therapeutics
OSO Biopharmaceuticals Manufacturing (acquired by AMRI)
Ottawa Hospital Research Institute
Oxford BioMedica
Pace Analytical
PaizaBio
Pall Life Sciences
Panacea Pharmaceuticals
Paragon Bioservices
Particle Measuring Systems
Partners Group
Patheon
PCI Pharma Services
Penn Pharmaceutical Services
Permira
Pfizer
Pfizer CentreOne
Pharmaceutical Packaging Professionals
Pierre Fabre
Piramal Pharma Solutions
Polpharma Biologics
Polymun Scientific
Praxis Pharmaceutical
PrimaPharma
Prince Sterilization Services
PSC Biotech
PYRAMID Laboratories
Quality BioResources
QureBio
Recipharm
Regeneron Pharmaceuticals
Reliance Life Sciences
Rentschler Biopharma
Rentschler Fill Solutions
Revance Therapeutics
Roche
Romaco
Rommelag CMO
RoslinCT
ROTA
Ruibo Bio-Technology
Russian Direct Investment Fund (RDIF)
Samsung Bioepis
Samsung Biologics
Sandoz
Sanofi
Saudi Biotechnology Manufacturing
Schematic Engineering Industries
SCHOTT
ScinoPharm
Seiko Epson
Selecta Biosciences
Sensorion
Shengnuo Peptide
Sherpa Clinical Packaging Packaging (acquired by PCI Pharma Services)
Shibuya
Shree Bhagwati Machtech (India)
SialoCarb
Siam Bioscience
Siegfried Holding
Singota Solutions
Sio Gene Therapies
SiO2 Medical Products
SIRION Biotech
Sirton Pharmaceuticals
SKAN
Snowbell Machines
SP
Square Pharmaceuticals
Staubli
Steriline
Surrozen
Swissfillon
Symbiosis Pharmaceutical
Symphogen
SynCo Bio Partners
Syngene
Synklino
Syntegon
Sypharma
National Health Research Institutes (NHRI)
Takara Bio
Tanvex BioPharma
Taysha Gene Therapies
Tekpak
The Carlyle Group
Therapure Biomanufacturing
Thermo Fisher Scientific
Tofflon
Transcoject
TriPharm Services (acquired by Alcami)
TRUKING
Tubulis
U.S. Army Contracting Command
UCB
Ultragenyx Pharmaceutical
Universal Robots
University of Queensland
USV
Vanrx
Vaxine
VBI Vaccines
Vetter Pharma
VGXI
Vibalogics
Vaccine and Infectious Disease Organization (VIDO)
Vigene Biosciences
Viralgen
VxP Biologics
WACKER Biotech
Waisman Biomanufacturing
Watson-Marlow Fund
West Pharmaceutical Services
WuXi Biologics
Wuxi Fortune Pharmaceutical
Wuxi Griffin
Yaskawa Electric
Yposkesi

Methodology

LOADING...

PURCHASE OPTIONS

Single User License PDF

Site License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4610EUR$4,799USD£3,958GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€6724EUR$6,999USD£5,773GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€17291EUR$17,999USD£14,846GBP

Table of Contents

Companies Mentioned

Methodology

Related Topics

Related Reports

Global Biologics Market by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies), Indication (Autoimmune Diseases, Cancer, Infectious Diseases), End-user - Forecast 2023-2030

Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Cell Culture Vessels, Single-Use Equipment), Process (Cell Processing, Preservation), Cell type (T-Cells, Stem cells), End User (Biopharma, CROs, CMOs), Region - Global Forecast to 2028

Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region - Global Forecast to 2028

Global Packaging Market is segmented based on Product, Type, End-Users, and Geography, Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession with Ansoff Analysis

Global Biopharmaceuticals Market Outlook to 2027